LB Pharmaceuticals Inc
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Assets | |||
| Cash & Equivalents | $250.2M | $23.0M | — |
| Accounts Receivable | — | — | — |
| Inventory | — | — | — |
| Total Current Assets | $308.4M | $28.9M | — |
| Property, Plant & Equipment | $1.6M | $1.9M | — |
| Goodwill | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — |
| Total Assets | $312.9M | $33.5M | — |
| Liabilities | |||
| Accounts Payable | $2.1M | $2.3M | — |
| Total Current Liabilities | $7.4M | $8.1M | — |
| Long-Term Debt | — | — | — |
| Total Liabilities | $11.6M | $13.8M | — |
| Stockholders' Equity | |||
| Retained Earnings | $-129.5M | $-104.3M | — |
| Total Stockholders' Equity | $301.3M | $-94.6M | $-34.5M |